To begin searching the abstracts, please use the search feature above.
| Saturday, 15 May | Sunday, 16 May | Monday, 17 May | Tuesday, 18 May | Wednesday, 19 May | Thursday, 20 May |
| 12:00 | Advancing Psychiatric Imaging: Psychoradiology & AI |
| Qiyong Gong | |
The primary aim of Psychoradiology is to translate findings from brain imaging research studies that identified brain alterations in patient groups into accurate diagnosis at an early stage of illness, prediction of prognosis before treatment, and guidance for selection of effective treatments that target patient-relevant pathophysiological features. Artificial intelligence (AI) is currently the best tool to achieve this goal. The present talk will therefore briefly summarize recent advances and related challenges in psychoradiological studies of AI applied to mental disorders. The results of these studies suggest that AI could be a powerful tool in assisting the clinicians in providing care for patients with mental disorders. In addition, present talk will also discuss the challenges of AI application in psychoradiology as well as the possible directions for future research. |
| 12:30 | Motion Correction in Neuroimaging |
| Kristina Pelkola |
| 13:00 | Cerebral 2D Cine Phase Contrast MRI |
| Olivier Baledent | |
Cerebral hydrodynamics knowledge has benefited considerably from the introduction of phase-contrast magnetic resonance imaging (PCMRI), the unique technique to investigate CSF and cerebral blood flows oscillations. Using post-processing software, key parameters of flow can be easily calculated. These flows data can be functional information’s complementary to the morphological imaging to better investigate the cranio-spinal system. The objective of this presentation is to describe the power and the limit of such clinical 2D PCMRI protocol concerning CSF and blood flow investigations in different healthy and pathological populations. |
| 14:00 | MRS in Pediatric Cancers |
| Stefan Bluml | |
This presentation is intended for MR technologists with interest in clinical application of MR spectroscopy for pediatric brain tumors. It provides an overview of basic principles of spectroscopy as well as practical advice when acquiring spectra in a clinical setting with emphasis on the need for consistency. Possible artifacts and pitfalls frequently encountered in the pediatric population will be discussed. |
| 14:30 | MRI of Neurodevelopment |
| Mai-Lan Ho | |
This talk will cover MRI of brain development, including age-related neurodevelopment, normal variants, and diagnostic pitfalls, and key findings in neurogenetic disorders. We will review key mechanisms of pediatric brain development based on major embryologic steps including dorsal induction, ventral induction, formation of midline commissures, migration, and organization. We will cover MRI of fetal, perinatal, and postnatal development, including myelination, sulcation, basal ganglia, pituitary, and ventricular findings. Multiple imaging examples of congenital brain malformations will be presented, linking MRI findings to underlying derangements of neurodevelopmental processes. |
| 15:00 | FBI: Foreign Body Investigation |
| Marty Sherriff | |
Imaging pediatric patients provides a unique imaging challenge for Technologists and Radiographers. Pediatrics imaging requires Technologist and Radiographers to have multiple ‘tools’ at their disposal to mitigate/reduce motion artifacts, achieve uniform fat suppression and provide imaging in a timely manner. Imaging the esophagus, which can be quickly damaged after an ingestion of the button battery, is surrounded by numerous organs (heart and lungs), blood vessels and airways. Compensating for air tissue interface susceptibility, reduction of motion from vessels and respiration, adapting coil configurations to the size of the patient. |
| 16:00 | Arthritis Imaging: Inflammatory Arthropathy |
| Chiara Giraudo | |
This lecture is for technicians, radiologists, and scientists interested in musculoskeletal imaging with a special focus on inflammatory rheumatic diseases. A comprehensive overview of inflammatory arthritis including pediatric diseases will be provided. The optimization of MR protocols according to international guidelines will be discussed. Moreover, the role of qualitative and quantitative MR imaging including advanced techniques, such as radiomics, machine learning, and artificial intelligence will be addressed. At the end of this lecture, the audience will have gained new knowledge about the diagnostic process for inflammatory arthritis and the application of basic and advanced MR imaging in this field. |
| 16:30 | Optimising MSK: What's New & Hot for Radiographers |
| Bac Nguyen | |
The aim of this presentation is to highlight many important key parameters to get tack sharp images, while keeping the scantime down. This presentation will mainly be focused on MSK 2D TSE sequences. With that said, many of the tips & tricks which will be given can be adapted to other organs as well.The parameters which will be focused on are very basic and can be found on every vendor and field strength. The second part of this presentation will be mainly focused on what’s new and hot out there among these vendors. |
| 17:00 | UTE Fat Suppression Technique for MSK |
| Hyungseok Jang | |
Fat suppression can improve detection of lesions or reduce imaging artifacts, and therefore is often utilized in musculoskeletal (MSK) imaging. Ultrashort echo time MSK (UTE-MSK) imaging can also benefit from fat suppression to better visualize short T2 tissues and lesions. However, the conventional fat suppression approaches such as two-point Dixon or fat-saturation may not be effective in UTE imaging due to the signal attenuation in short T2 tissues. In this talk, we will review alternative approaches for fat suppression in UTE imaging, including single-point Dixon, UTE-IDEAL, single or dual IR based methods, multi-component analysis, and soft-hard pulse based water excitation. |
| 18:00 | IDH-Mutated Glioma/Glioma MR (Since 2016 WHO Guideline Update) |
| Anja van der Kolk | |
In this lecture, we will discuss what a glioma is, how gliomas were classified before the 2016 WHO Brain Tumor Classification update, and why this classification scheme changed from focusing solely on histopathology (or light microscopy) to combining both histopathological and genetic and molecular features of glioma cells. We will then zoom in on several of the genetic and molecular features that are relevant for the WHO classification of gliomas. We will end our journey through gliomagenesis with an overview of how these genetic and molecular features affect and even improve our MRI techniques and protocols for glioma imaging. |
| 18:30 | MR Protocols for Detecting IDH-Mutated Glioma |
| Alexander Lin |
| 19:00 | In Vivo MR Spectroscopy: Practical Aspects of 2HG Acquisition |
| Ho-Beom Lee | |
The topic is practical aspects of 2HG acquisition in MR spectroscopy We will focus on the factors that should be considered when acquiring in MR scanner rather than the theoretical content. |
| 0:00 | Trials & Tribulations of Translation into Meaningful Outcomes for the Patient |
| Carolyn Mountford |
| 0:30 | MR Spectroscopy in Neurological Diseases, Infections & Cancer |
| Eva-Maria Ratai |
| 2:00 | MRI for Visualization & Characterization of Bladder Cancer |
| Huyen Harmony Nguyen | |
This talk will discuss the applications of structural and quantitative MRI in the diagnosis and therapeutic monitoring of bladder cancer. The values of conventional techniques (T2W, T1W), DCE-MRI, and DWI in bladder cancer imaging will be presented with findings from different studies. |
| 2:30 | Liver MRI: Focal Liver Lesions in the Non-Cirrhotic & Cirrhotic Liver |
| Alison Harris | |
This talk aims to provide an overview of the commonly encountered focal liver lesions that are identified and characterized with MRI outlining their typical appearances. The utility of sequences such as DWI in helping to determine the nature of the liver lesion and patterns of contrast enhancement pattern is discussed. The use of hepato-biliary contrast agents and value in lesion characterization and detection of liver metastases is outlined. Examples of benign and malignant lesions, highlighting typical appearances, are displayed. |
| 3:00 | Diffusion Imaging in the Body |
| James Hancock | |
Diffusion Imaging in applications outside of the Brain and Spine continue to grow. The focus of this presentation is on Single Shot EPI Diffusion Weighted imaging in body applications and how it can be optimised to improve image quality of both diffusion images and ADC maps. An introduction into the more advanced multishot and reduced FOV DWI is also discussed and the best applications for these newer techniques. |
| 6:00 | 4D Flow MRI |
| Marci Messina |
| 6:30 | CEST Imaging: Technology & Applications |
| Weiqiang Dou | |
The basic concept of CEST mechanism is first provided. Different types of CEST saturation schemes and readout methods as well as novel post-processing methods are then introduced with their respective pros and cons. With these techniques, novel clinical applications are extensively reviewed by focusing on specific chemical compounds of NH, NH2 and OH. |
| 7:00 | Synthetic MR in Neuroradiology |
| Alex Rovira | |
Synthetic MRI is a multi dynamic multi echo sequence that provides quantitative T1, T2, proton density and myelin maps and a full set of clinical images to be generated from a single acquisition. This technique could be considered a time-efficient alternative to conventional MR imaging to visualize and quantify brain tissue properties, and has the potential to facilitate the clinical implementation of standardized and harmonized quantitative MRI measurements as a robust imaging biomarker for tissue characterization. |
| 8:00 | Magnetisation: Fields & Forces |
| Donald McRobbie |
| 12:00 | Tumour Heterogeneity in Ovarian & Kidney Cancers |
| Evis Sala | |
Intra-tumour heterogeneity is present on various levels in ovarian and kidney cancers. Different tumour regions are genetically heterogeneous, show a variable physiology, different metabolic profiles and different morphological appearances. Each of these properties can be investigated in isolation, done typically in the past. Our aim is, however, to understand where Imaging, Transcriptomics, Genomics and Metabolomics provide complementary information and where information is redundant. For this, we require spatially resolved data integration which is key to biological understanding of what we see on imaging as well as for non-invasive evaluation of tumour micro-environment and better prediction of treatment response and outcome. |
| 12:30 | Diffusion & DCE in Chemotherapy Response |
| Sungheon Gene Kim | |
Diffusion and DCE-MRI have become important techniques in various areas of cancer imaging including diagnosis, tumor grading, and treatment response evaluation and prediction. The rapid development of new diffusion and perfusion techniques owing to the recent advance in MR hardware and emerging new microstructure models have shown a promising trend to expand the scope of dMRI and DCE-MRI to become a powerful tool in cancer imaging to study tumor heterogeneity, vascularity, cellularity, and microstructural properties. Diffusion and DCE-MRI can provide quantitative measurement of antiangiogenic and cytotoxic effect of chemotherapy. |
| 13:00 | MR-Guided Radiotherapy |
| Glenn Cahoon | |
Radiotherapy is one of the most effective cancer treatments available with almost half of all cancer patients receive radiation treatment over the course of their disease. With an increasing number of people surviving cancer, emphasis is being placed on reducing treatment side effects. Improvements in radiation treatment planning and delivery are reliant on accurately visualizing and localising the disease as well as normal tissue structures. Traditionally CT imaging has been used for treatment planning and dose calculation, however, MRI with its superior soft tissue contrast, is increasingly being incorporated into the RT workflow to improve lesion definition and disease extent. |
| 14:00 | Go with the Flow: Lessons Learned About the Importance of Radiologist-Technologist Teamwork in the Development of MRA |
| Thomas Grist |
| 16:00 | Gadolinium-Based Contrast Media |
| Matthew Davenport | |
Gadolinium-based contrast media are safe. Key potential risks include: nephrogenic systemic fibrosis, hypersensitivity reactions and gadolinium retention. These risks differ between the different GBCM. The risk of NSF from Group II GBCM is very small (upper bound risk: 0.07%). The risk of NSF from Group III GBCM likely small, but more data needed (upper bound risk: 1.1%). Gadolinium retention occurs, but has unclear importance; patient handouts now available. Immediate reactions are rare (0.09%), but breakthrough reactions are common (40%). GBCA tradeoffs require thought. Consider both the provider's and patient’s point of view. |
| 16:30 | Implants |
| Ross Venook |
| 17:00 | Implementing E-Learning MR Safety Training |
| Paula Ciccozzi | |
There is a potential risk of injury or death of patients and personnel exposed to the MRI environment if safety procedures are not followed. Formal MRI safety education is one of the most critical components of ensuring awareness of MRI hazards and safety practices to protect employees and patients from harm. The presentation discusses how we designed and introduced an e-learning MRI safety training module for non-MRI personnel at WCH. This aimed to encourage an MRI safety aware culture to help reduce the incident rate for MRI related events or risk of harm to patients and personnel. |
| 18:00 | Post-Processing MR into CT-Like Images |
| Jeff Chen | |
MRI may be able to replace the need for CT for osseous injury, significantly reducing exposure to ionizing radiation and enabling MRI to be a one-stop imaging modality for pediatric trauma studies and further prevent any delays of patient’s treatment or having more scans that may prolong hospital stay. 3D spoiled gradient echo sequences such as the T1 eTHRIVE / LAVA / VIBE and the T2* mFFE / MERGE / MEDIC can produce CT-like images has demonstrated its ability to show fractures and surrounding soft tissue structures. |
| 18:30 | Automatic Post-Processing in the Cloud Space |
| Kevin King | |
The rise of cloud-based computing has heralded a fundamental shift in the way radiology evaluates images. In large part, this is not due to development of new imaging analysis tools, but rather automation of these tools using basic imaging analysis tools which have been well developed in the research setting. The standardization brought about by lack of user interaction has impacted how these imaging tools are validated and how findings are disseminated. Further benefits from automation may help to reduce monotony while supporting the high efficiency expected of radiology. |
| 19:00 | Clinical Applications of fMRI & DTI in Neuro-Oncology |
| Foteini Christidi | |
Functional MRI and diffusion tensor imaging are increasingly incorporated in clinical practice in order to identify eloquent brain regions. The latter is important in case of brain tumors where pre-operative identification of these regions may affect the surgical procedure and predict post-operative clinical outcome. In this 30min educational session, we will explore the fundamental clinical applications of task and resting-state fMRI and DTI/Tractography in neuro-oncology by processing pre-operative fMRI and DTI data of real brain tumor cases and discussing pre-operative findings with regards to findings from electrical stimulation and patients’ post-operative clinical outcome. |
0:00
|
Induction: Electric Fields & Bio-Effects | |
| Donald McRobbie | ||
4:30
|
Cardiac MR Findings of Cardiac Involvement in COVID-19 Recovered Patients | |
| Lu Huang1 and Liming Xia2 | ||
1Tongji Hospital，Tongji Medical College, Huazhong University of Science and Technology, China, 2Radiology, Tongji Hospital，Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China |
||
Cardiac magnetic resonance (CMR) evaluated cardiac involvement in patients recovered from COVID- 19 . Myocardial injury caused by COVID-19 was previously reported in hospitalized patients. It is unknown if there is sustained cardiac involvement after patients’ recovery from COVID-19. Cardiac involvement was found in a proportion of patients recovered from COVID-19. CMR manifestation included myocardial edema, fibrosis, and impaired ventricle function.CMR myocardial tissue and strain imaging parameters suggest that a proportion of participants recovered from COVID-19 had subclinical myocardial abnormalities detectable months after recovery. These CMR findings indicate the need for ongoing investigation of the long-term cardiovascular consequences of COVID-19. |
5:00
|
Infection Control (Reflective vs. Instructional, New Developments) | |
| Lauren Scannell1 | ||
1Brigham & Women's Hospital, United States |
8:00
|
Radiographers/Technologists Reporting CMR Scans: Is it Possible & How to Implement It | |
| Kevin Strachan1 | ||
1NUH trust |
8:30
|
How to Organize/Create Efficient Organization | |
| Shawna Farquharson1 | ||
1The Florey Institute of Neuroscience & Mental Health, Melbourne, Australia |
9:00
|
Patient-Centered Care: How Techs/Radiographers Look Out for Ourselves | |
| James Stuppino1 | ||
1AnimalScan, LLC, United States |
14:00
|
Myocardial T1, T2, T2* & ECV Mapping: The Clinical Promise | |
| Wiphada Patricia Bandettini1 | ||
1NIH/NHLBI, Bethesda, MD, United States |
||
• Parametric mapping tissue characterization has moved beyond the research realm and is now applicable within the clinical setting. Parametric mapping adds value to CMR, taking imaging beyond that of anatomy. Native T1, T2, and T2* offer non-contrast options to better characterize the myocardium. Extracellular volume fraction (ECV) helps to identify edema diffuse fibrosis. Edema, inflammation, fibrosis, and infiltration may be identified noninvasively by CMR. The tools of T1, T2, T2*, and ECV are ready for daily clinical use…if the appropriate QA and standards are followed. Parametric mapping offers improved diagnosis, management, and prognosis in the patient with cardiovascular disease. |
14:30
|
Myocardial T1, T2, T2* & ECV Mapping: Challenges in the Field | |
| Alison Fletcher1 | ||
1University of Oxford, United Kingdom |
15:00
|
Myocardial T1, T2, T2* & ECV Mapping: Upcoming Technical Solutions to Practical Problems | |
| Jesse I. Hamilton1 | ||
1University of Michigan, Ann Arbor, MI, United States |
||
This presentation will cover recent technical advances in myocardial T1, T2, T2*, and ECV mapping. First, a review of conventional cardiac parameter mapping methods will be presented including MOLLI and SASHA (T1 mapping), T2-prepared gradient echo (T2 mapping), and multi-echo gradient echo (T2* mapping). Next, we will discuss recent technical innovations that address practical challenges in parameter mapping including motion correction, high-resolution 3D mapping, multiparametric techniques, free-running techniques, and deep learning for parameter mapping. |
18:00
|
MRI for Visualization & Characterization of Bladder Cancer | |
| Huyen Harmony Nguyen1 | ||
1Calyx, United States |
||
This talk will discuss the applications of structural and quantitative MRI in the diagnosis and therapeutic monitoring of bladder cancer. The values of conventional techniques (T2W, T1W), DCE-MRI, and DWI in bladder cancer imaging will be presented with findings from different studies. |
18:30
|
Liver MRI: Focal Liver Lesions in the Non-Cirrhotic & Cirrhotic Liver | |
| Alison Harris | ||
This talk aims to provide an overview of the commonly encountered focal liver lesions that are identified and characterized with MRI outlining their typical appearances. The utility of sequences such as DWI in helping to determine the nature of the liver lesion and patterns of contrast enhancement pattern is discussed. The use of hepato-biliary contrast agents and value in lesion characterization and detection of liver metastases is outlined. Examples of benign and malignant lesions, highlighting typical appearances, are displayed. |
19:00
|
Diffusion Imaging in the Body | |
| James Hancock1 | ||
1University of Queensland, Australia |
||
Diffusion Imaging in applications outside of the Brain and Spine continue to grow. The focus of this presentation is on Single Shot EPI Diffusion Weighted imaging in body applications and how it can be optimised to improve image quality of both diffusion images and ADC maps. An introduction into the more advanced multishot and reduced FOV DWI is also discussed and the best applications for these newer techniques. |
0:00
|
MRS in Pediatric Cancers | |
| Stefan Bluml1 | ||
1Children's Hospital Los Angeles, United States |
||
This presentation is intended for MR technologists with interest in clinical application of MR spectroscopy for pediatric brain tumors. It provides an overview of basic principles of spectroscopy as well as practical advice when acquiring spectra in a clinical setting with emphasis on the need for consistency. Possible artifacts and pitfalls frequently encountered in the pediatric population will be discussed. |
0:30
|
MRI of Neurodevelopment | |
| Mai-Lan Ho1 | ||
1Nationwide Children’s Hospital, Columbus, OH, United States |
||
This talk will cover MRI of brain development, including age-related neurodevelopment, normal variants, and diagnostic pitfalls, and key findings in neurogenetic disorders. We will review key mechanisms of pediatric brain development based on major embryologic steps including dorsal induction, ventral induction, formation of midline commissures, migration, and organization. We will cover MRI of fetal, perinatal, and postnatal development, including myelination, sulcation, basal ganglia, pituitary, and ventricular findings. Multiple imaging examples of congenital brain malformations will be presented, linking MRI findings to underlying derangements of neurodevelopmental processes. |
1:00
|
FBI: Foreign Body Investigation | |
| Marty Sherriff1 | ||
1Alberta Children's Hospital, Canada |
||
Imaging pediatric patients provides a unique imaging challenge for Technologists and Radiographers. Pediatrics imaging requires Technologist and Radiographers to have multiple ‘tools’ at their disposal to mitigate/reduce motion artifacts, achieve uniform fat suppression and provide imaging in a timely manner. Imaging the esophagus, which can be quickly damaged after an ingestion of the button battery, is surrounded by numerous organs (heart and lungs), blood vessels and airways. Compensating for air tissue interface susceptibility, reduction of motion from vessels and respiration, adapting coil configurations to the size of the patient. |
6:00
|
Conduction: Tissue & Implant Heating | |
| Donald McRobbie | ||
8:00
|
IDH-Mutated Glioma/Glioma MR (Since 2016 WHO Guideline Update) | |
| Anja G. van der Kolk1 | ||
1University Medical Center Utrecht, Utrecht, Netherlands |
||
In this lecture, we will discuss what a glioma is, how gliomas were classified before the 2016 WHO Brain Tumor Classification update, and why this classification scheme changed from focusing solely on histopathology (or light microscopy) to combining both histopathological and genetic and molecular features of glioma cells. We will then zoom in on several of the genetic and molecular features that are relevant for the WHO classification of gliomas. We will end our journey through gliomagenesis with an overview of how these genetic and molecular features affect and even improve our MRI techniques and protocols for glioma imaging. |
8:30
|
MR Protocols for Detecting IDH-Mutated Glioma | |
| Alexander Peter Lin1 | ||
1Center for Clinical Spectroscopy, Brigham and Women's Hospital/Harvard Med School, Boston, MA, United States |
9:00
|
12:00
|
4D Flow MRI | |
| Marci Messina1 | ||
1Northwestern Hospital, United States |
12:30
|
CEST Imaging: Technology & Applications | |
| Weiqiang Dou1 | ||
1MR Research, GE Healthcare China, China |
||
The basic concept of CEST mechanism is first provided. Different types of CEST saturation schemes and readout methods as well as novel post-processing methods are then introduced with their respective pros and cons. With these techniques, novel clinical applications are extensively reviewed by focusing on specific chemical compounds of NH, NH2 and OH. |
13:00
|
Synthetic MR in Neuroradiology | |
| Alex Rovira1 | ||
1Hospital Universitari Vall d’Hebron, Spain |
||
Synthetic MRI is a multi dynamic multi echo sequence that provides quantitative T1, T2, proton density and myelin maps and a full set of clinical images to be generated from a single acquisition. This technique could be considered a time-efficient alternative to conventional MR imaging to visualize and quantify brain tissue properties, and has the potential to facilitate the clinical implementation of standardized and harmonized quantitative MRI measurements as a robust imaging biomarker for tissue characterization. |
14:00
|
14:30
|
Patient-Centered Care: How Techs/Radiographers Look Out for Ourselves | |
| James Stuppino1 | ||
1AnimalScan, LLC, United States |
15:00
|
0:00
|
Attenuation: Acoustic Noise Generation & Reduction | |
| Donald McRobbie | ||
2:00
|
Gadolinium-Based Contrast Media | |
| Matthew S Davenport1 | ||
1University of Michigan, Ann Arbor, MI, United States |
||
Gadolinium-based contrast media are safe. Key potential risks include: nephrogenic systemic fibrosis, hypersensitivity reactions and gadolinium retention. These risks differ between the different GBCM. The risk of NSF from Group II GBCM is very small (upper bound risk: 0.07%). The risk of NSF from Group III GBCM likely small, but more data needed (upper bound risk: 1.1%). Gadolinium retention occurs, but has unclear importance; patient handouts now available. Immediate reactions are rare (0.09%), but breakthrough reactions are common (40%). GBCA tradeoffs require thought. Consider both the provider's and patient’s point of view. |
2:30
|
Implants | |
| Ross Venook1 | ||
1Stanford University, United States |
3:00
|
Implementing E-Learning MR Safety Training | |
| Paula Ciccozzi1 | ||
1Women & Children's Hospital, Australia |
||
There is a potential risk of injury or death of patients and personnel exposed to the MRI environment if safety procedures are not followed. Formal MRI safety education is one of the most critical components of ensuring awareness of MRI hazards and safety practices to protect employees and patients from harm. The presentation discusses how we designed and introduced an e-learning MRI safety training module for non-MRI personnel at WCH. This aimed to encourage an MRI safety aware culture to help reduce the incident rate for MRI related events or risk of harm to patients and personnel. |
4:00
|
Advancing Psychiatric Imaging: Psychoradiology & AI | |
| Qiyong Gong1 and Huaiqiang Sun1 | ||
1Huaxi MR Research Center (HMRRC), West China Hospital of Sichuan University, China |
||
The primary aim of Psychoradiology is to translate findings from brain imaging research studies that identified brain alterations in patient groups into accurate diagnosis at an early stage of illness, prediction of prognosis before treatment, and guidance for selection of effective treatments that target patient-relevant pathophysiological features. Artificial intelligence (AI) is currently the best tool to achieve this goal. The present talk will therefore briefly summarize recent advances and related challenges in psychoradiological studies of AI applied to mental disorders. The results of these studies suggest that AI could be a powerful tool in assisting the clinicians in providing care for patients with mental disorders. In addition, present talk will also discuss the challenges of AI application in psychoradiology as well as the possible directions for future research. |
4:30
|
Motion Correction in Neuroimaging | |
| Kristina Pelkola1 | ||
1Boston Children's Hospital, United States |
5:00
|
Cerebral 2D Cine Phase Contrast MRI | |
| Olivier Baledent1,2 | ||
1University of Amiens, Amiens, France, 2university hospital of Picardie Jules Verne, Amiens, France |
||
Cerebral hydrodynamics knowledge has benefited considerably from the introduction of phase-contrast magnetic resonance imaging (PCMRI), the unique technique to investigate CSF and cerebral blood flows oscillations. Using post-processing software, key parameters of flow can be easily calculated. These flows data can be functional information’s complementary to the morphological imaging to better investigate the cranio-spinal system. The objective of this presentation is to describe the power and the limit of such clinical 2D PCMRI protocol concerning CSF and blood flow investigations in different healthy and pathological populations. |
6:00
|
MR Spectroscopy of Neurological Disease, Infections & Cancer | |
| Eva-Maria Ratai1 | ||
1Massachusetts General Hospital, Charlestown, MA, United States |
6:30
|
Trials & Tribulations of Translation into Meaningful Outcomes for the Patient | |
| Carolyn Mountford1 | ||
1Translational Research Institute Australia, Brisbane, Australia |
7:00
|
Go with the Flow: Lessons Learned About the Importance of Radiologist-Technologist Teamwork in the Development of MRA | |
| Thomas Grist1 | ||
1University of Wisconsin, Madison, United States |
2:00
|
Application: Putting it All Together for Patient Safety | |
| Donald McRobbie | ||
4:00
|
Arthritis Imaging: Inflammatory Arthropathy | |
| Chiara Giraudo1 | ||
1University of Padova, Padova, Italy |
||
This lecture is for technicians, radiologists, and scientists interested in musculoskeletal imaging with a special focus on inflammatory rheumatic diseases. A comprehensive overview of inflammatory arthritis including pediatric diseases will be provided. The optimization of MR protocols according to international guidelines will be discussed. Moreover, the role of qualitative and quantitative MR imaging including advanced techniques, such as radiomics, machine learning, and artificial intelligence will be addressed. At the end of this lecture, the audience will have gained new knowledge about the diagnostic process for inflammatory arthritis and the application of basic and advanced MR imaging in this field. |
4:30
|
Optimising MSK: What's New & Hot for Radiographers | |
| Bac Nguyen1 | ||
1Oslo University Hospital, Norway |
||
The aim of this presentation is to highlight many important key parameters to get tack sharp images, while keeping the scantime down. This presentation will mainly be focused on MSK 2D TSE sequences. With that said, many of the tips & tricks which will be given can be adapted to other organs as well.The parameters which will be focused on are very basic and can be found on every vendor and field strength. The second part of this presentation will be mainly focused on what’s new and hot out there among these vendors. |
5:00
|
UTE Fat Suppression Technique for MSK | |
| Hyungseok Jang1 | ||
1University of California, San Diego, La Jolla, CA, United States |
||
Fat suppression can improve detection of lesions or reduce imaging artifacts, and therefore is often utilized in musculoskeletal (MSK) imaging. Ultrashort echo time MSK (UTE-MSK) imaging can also benefit from fat suppression to better visualize short T2 tissues and lesions. However, the conventional fat suppression approaches such as two-point Dixon or fat-saturation may not be effective in UTE imaging due to the signal attenuation in short T2 tissues. In this talk, we will review alternative approaches for fat suppression in UTE imaging, including single-point Dixon, UTE-IDEAL, single or dual IR based methods, multi-component analysis, and soft-hard pulse based water excitation. |
6:00
|
Tumour Heterogeneity in Ovarian & Kidney Cancers | |
| Evis Sala1 | ||
1University of Cambridge, Cambridge, United Kingdom |
||
Intra-tumour heterogeneity is present on various levels in ovarian and kidney cancers. Different tumour regions are genetically heterogeneous, show a variable physiology, different metabolic profiles and different morphological appearances. Each of these properties can be investigated in isolation, done typically in the past. Our aim is, however, to understand where Imaging, Transcriptomics, Genomics and Metabolomics provide complementary information and where information is redundant. For this, we require spatially resolved data integration which is key to biological understanding of what we see on imaging as well as for non-invasive evaluation of tumour micro-environment and better prediction of treatment response and outcome. |
6:30
|
Diffusion & DCE in Chemotherapy Response | |
| Sungheon Gene Kim1 | ||
1Weill Cornell Medical College, New York, NY, United States |
||
Diffusion and DCE-MRI have become important techniques in various areas of cancer imaging including diagnosis, tumor grading, and treatment response evaluation and prediction. The rapid development of new diffusion and perfusion techniques owing to the recent advance in MR hardware and emerging new microstructure models have shown a promising trend to expand the scope of dMRI and DCE-MRI to become a powerful tool in cancer imaging to study tumor heterogeneity, vascularity, cellularity, and microstructural properties. Diffusion and DCE-MRI can provide quantitative measurement of antiangiogenic and cytotoxic effect of chemotherapy. |
7:00
|
MR-Guided Radiotherapy | |
| Glenn Cahoon1 | ||
1Olivia Newton-John Cancer Wellness & Research Centre, Australia |
||
Radiotherapy is one of the most effective cancer treatments available with almost half of all cancer patients receive radiation treatment over the course of their disease. With an increasing number of people surviving cancer, emphasis is being placed on reducing treatment side effects. Improvements in radiation treatment planning and delivery are reliant on accurately visualizing and localising the disease as well as normal tissue structures. Traditionally CT imaging has been used for treatment planning and dose calculation, however, MRI with its superior soft tissue contrast, is increasingly being incorporated into the RT workflow to improve lesion definition and disease extent. |
8:00
|
Post-Processing MR into CT-Like Images | |
| Jeff Chien-Fu Chen1 | ||
1Monash Children's Hospital, Australia |
||
MRI may be able to replace the need for CT for osseous injury, significantly reducing exposure to ionizing radiation and enabling MRI to be a one-stop imaging modality for pediatric trauma studies and further prevent any delays of patient’s treatment or having more scans that may prolong hospital stay. 3D spoiled gradient echo sequences such as the T1 eTHRIVE / LAVA / VIBE and the T2* mFFE / MERGE / MEDIC can produce CT-like images has demonstrated its ability to show fractures and surrounding soft tissue structures. |
8:30
|
Automatic Post-Processing in the Cloud Space | |
| Kevin King1 | ||
1Barrow Neurological Institute, United States |
||
The rise of cloud-based computing has heralded a fundamental shift in the way radiology evaluates images. In large part, this is not due to development of new imaging analysis tools, but rather automation of these tools using basic imaging analysis tools which have been well developed in the research setting. The standardization brought about by lack of user interaction has impacted how these imaging tools are validated and how findings are disseminated. Further benefits from automation may help to reduce monotony while supporting the high efficiency expected of radiology. |
9:00
|
Clinical Applications of fMRI & DTI in Neuro-Oncology | |
| Foteini Christidi1 | ||
1Advantis Medical Imaging, Greece |
||
Functional MRI and diffusion tensor imaging are increasingly incorporated in clinical practice in order to identify eloquent brain regions. The latter is important in case of brain tumors where pre-operative identification of these regions may affect the surgical procedure and predict post-operative clinical outcome. In this 30min educational session, we will explore the fundamental clinical applications of task and resting-state fMRI and DTI/Tractography in neuro-oncology by processing pre-operative fMRI and DTI data of real brain tumor cases and discussing pre-operative findings with regards to findings from electrical stimulation and patients’ post-operative clinical outcome. |
12:00
|
14:00
|
14:30
|
Cardiac MR Findings of Cardiac Involvement in COVID-19 Recovered Patients | |
| Lu Huang1 and Liming Xia2 | ||
1Tongji Hospital，Tongji Medical College, Huazhong University of Science and Technology, China, 2Radiology, Tongji Hospital，Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China |
||
Cardiac magnetic resonance (CMR) evaluated cardiac involvement in patients recovered from COVID- 19 . Myocardial injury caused by COVID-19 was previously reported in hospitalized patients. It is unknown if there is sustained cardiac involvement after patients’ recovery from COVID-19. Cardiac involvement was found in a proportion of patients recovered from COVID-19. CMR manifestation included myocardial edema, fibrosis, and impaired ventricle function.CMR myocardial tissue and strain imaging parameters suggest that a proportion of participants recovered from COVID-19 had subclinical myocardial abnormalities detectable months after recovery. These CMR findings indicate the need for ongoing investigation of the long-term cardiovascular consequences of COVID-19. |
15:00
|
Infection Control (Reflective vs. Instructional, New Developments) | |
| Lauren Scannell1 | ||
1Brigham & Women's Hospital, United States |